{"slideshow_credits": null, "snippet": "The drug, Iclusig, has been linked to severe heart attacks and strokes, blindness and loss of blood flow in the extremities that can require amputation.", "abstract": "Food and Drug Administration suspends sales of promising leukemia drug Iclusig, made by Ariad, due to risk of life-threatening blood clots and severe narrowing of blood vessels.", "section_name": "Business Day", "print_page": "4", "document_type": "article", "byline": {"person": [{"firstname": "Denise", "role": "reported", "lastname": "GRADY", "rank": 1, "organization": ""}], "original": "By DENISE GRADY", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/11/01/business/serious-danger-of-blood-clots-halts-sale-of-leukemia-drug.html", "lead_paragraph": "The drug, Iclusig, has been linked to severe heart attacks and strokes, blindness and loss of blood flow in the extremities that can require amputation.", "headline": {"main": "Serious Danger of Blood Clots Halts Sale of Leukemia Drug", "print_headline": "Serious Danger of Blood Clots Halts Sale of Leukemia Drug"}, "_id": "5272f5e938f0d829b45e935a", "word_count": "398", "multimedia": [], "pub_date": "2013-11-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Ariad Pharmaceuticals Inc", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Iclusig (Drug)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Leukemia", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}